Nulliparous and parous women aged 18-35 years with regular menstrual cycles ( 21-35 days ) requesting contraception were randomized to 3 years of treatment with one of two levonorgestrel intrauterine contraceptive systems : 13.5 mg total content or 19.5 mg total content .